Sun Pharmaceutical Industries
SUNPHARMA · Pharma > Pharmaceuticals & Drugs · Chairman: Israel Makov · MD: Dilip S Shanghvi · Listing date: Feb. 8, 1995 · Employees: 37000 · Mumbai · http://www.sunpharma.com

Stock Price vs Company Growth
1d
0.3%
1w
1.8%
1m
13.9%
3m
31.4%
6m
40.2%
1y
61.9%
5y
30.4%
10y
10.3%
all
18.3%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

1,557 0.3%
1,179
1,568
Company Overview

Sales
47,445 Cr
Growth: 11.8%
Profit after Tax
8,906 Cr
Growth: 4.2%
Large Cap
3,73,564 Cr
P/E: 42.0x
Industry P/E: 34.3x
Fundamentals

Sales (Cr) ₹ 47,445
Growth 11.8%
EBITDA 26.7%
P/S 7.9x
Dividend 1.1%
P/E 42.0x
Book Value ₹ 262
PEG Ratio 3.6x
ROE 15.0%
P/B 5.9x
Shareholding Pattern

Institutions
Life Insurance Corporation Of India
7.37 %
Icici Prudential Value Discovery Fund And Various Fund Accounts
3.68 %
Sbi-Etf Nifty 50 And Various Fund Accounts
1.94 %
Hdfc Trustee Company Limited-Hdfc Balanced Advantage Fund And Various Fund Accounts
1.37 %
Nippon Life India Trustee Ltd-A/C Nippon India Pharma Fund And Various Fund Accounts
1.24 %
Promoters
Shanghvi Finance Private Limited
40.3 %
Dilip.S.Shanghvi
9.6 %
Aditya Medisales Limited
1.67 %
Raksha S.Valia
1.2 %
Sudhir V.Valia
0.6 %
Others
Llp
2.89 %
Lakshdeep Investments & Finance (P) Ltd.
1.18 %
Iepf
0.08 %
Increase    Decrease    No change
Company Profile Detailed

The company is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted by customers and patients in many countries across the world, at affordable prices.ProductsFormulationsActive Pharmaceutical Ingredients - CramsOTCAwards 2005: Dilip Shanghvi is named Entrepreneur of the Year (Healthcare and Life Science) Ernst & Young.
Investors (336)
Followers (134)